Jia, Yong
Yun, Cai-Hong
Park, Eunyoung
Ercan, Dalia
Manuia, Mari
Juarez, Jose
Xu, Chunxiao
Rhee, Kevin
Chen, Ting
Zhang, Haikuo
Palakurthi, Sangeetha
Jang, Jaebong
Lelais, Gerald
DiDonato, Michael
Bursulaya, Badry
Michellys, Pierre-Yves
Epple, Robert
Marsilje, Thomas H.
McNeill, Matthew
Lu, Wenshuo
Harris, Jennifer
Bender, Steven
Wong, Kwok-Kin
Jänne, Pasi A.
Eck, Michael J.
Article History
Received: 15 October 2015
Accepted: 29 March 2016
First Online: 25 May 2016
Competing interests
: K.-K.W. has an equity interest in G1 Therapeutics and Gatekeeper Pharmaceuticals, and has sponsored research agreements with AstraZeneca and Gilead Pharmaceuticals. P.A.J. receives sponsored research support from AstraZeneca; has ownership interest (including patents) in Gatekeeper Pharmaceuticals; is a consultant/advisory board member for AstraZeneca, Boehringer Ingelheim, Chugai Pharmaceuticals, Clovis Oncology, Genentech, Merrimack, Pfizer, and Sanofi. M.J.E. is a consultant for and receives sponsored research support from Novartis Institutes for Biomedical Research.